View source for Modeling predicts that CRISPR-based activators, unlike CRISPR-based repressors, scale well with increasing gRNA competition and dCas9 bottlenecking

From Murray Wiki
Jump to navigationJump to search

You do not have permission to edit this page, for the following reason:

The action you have requested is limited to users in the group: Users.


You can view and copy the source of this page.

Template used on this page:

Return to Modeling predicts that CRISPR-based activators, unlike CRISPR-based repressors, scale well with increasing gRNA competition and dCas9 bottlenecking.